Literature DB >> 17462527

Acute coronary syndromes in the elderly.

Farhan Majeed1, Mark D Kelemen.   

Abstract

Elderly patients with acute coronary syndromes suffer higher mortality and more morbidity than their younger counterparts because they have higher prevalence of cardiac risk factors and have lived with those risk factors longer, physiologic effects of aging lead to sicker patients at presentation and impaired healing processes, they are more sensitive to some of the side effects of some of our higher risk therapies, and they are less likely to receive therapies that have been proven to improve outcome. Close attention must be paid to risk assessment. We must continue to strive to match risky therapies to high-risk patients, those more likely to derive benefit. Age remains one of the most powerful cardiac risk factors of all.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462527     DOI: 10.1016/j.cger.2007.01.004

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  3 in total

Review 1.  Use of low-molecular-weight heparins and new anticoagulants in elderly patients with renal impairment.

Authors:  Meyer Michel Samama
Journal:  Drugs Aging       Date:  2011-03-01       Impact factor: 3.923

2.  Association Between Endophthalmitis and the Incidence of Acute Coronary Syndrome in Patients With Ankylosing Spondylitis: A Nationwide, Population-Based Cohort Study.

Authors:  Ting-Yi Lin; Yi-Fen Lai; Wu-Chien Chien; Yi-Hao Chen; Chien-An Sun; Chi-Hsiang Chung; Jiann-Torng Chen; Ching-Long Chen
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

3.  Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6.

Authors:  Bin Yang; Chunyan Zheng; Haichu Yu; Rui Zhang; Shan Li; Min Len; Shanglang Cai
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.